Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants

The combination of sulfadiazine and pyrimethamine plus folinic acid is the conventional treatment for congenital toxoplasmosis. However, this classical treatment presents teratogenic effects and bone marrow suppression. In this sense, new therapeutic strategies are necessary to reduce these effects...

詳細記述

書誌詳細

主要な著者:	Idessania Nazareth Costa, Mayara Ribeiro, Priscila Silva Franco, Rafaela José da Silva, Thádia Evelyn de Araújo, Iliana Claudia Balga Milián, Luana Carvalho Luz, Pâmela Mendonça Guirelli, Gerson Nakazato, José Roberto Mineo, Tiago W. P. Mineo, Bellisa Freitas Barbosa, Eloisa Amália Vieira Ferro
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2021-01-01
シリーズ:	Frontiers in Microbiology
主題:	Toxoplasma gondii trophoblast placenta nanoparticles treatment congenital toxoplasmosis
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fmicb.2020.623947/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!